CLSPN knockdown significantly reduced the proliferative ability of renal cell carcinoma cells [95] and prostate cancer cell lines [99,100], decreased migration and invasion, and promoted apoptosis [100]. This evidence concerns the gene CLSPN and prostate cancer.